Observational Study to Monitor Safety and Effectiveness of Obinutuzumab in Follicular Lymphoma or Previously Untreated Chronic Lymphocytic Leukemia
Clinical trial NCT03374137 · COMPLETED
Trial details
- NCT number
- NCT03374137
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-03-09
- Primary completion
- 2022-11-10
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.